Press release
-
Press Release
LG released new version of generative AI, EXAONE 3.5
– Following EXAONE 3.0 in August, EXAONE 3.5 version was released as open source on the 9th of this month,…
Read More » -
Press Release
Group Elephant business Valcann named Latin America’s ‘AWS Collaboration Partner of the Year’
ATLANTA, Dec. 9, 2024 /PRNewswire/ — AWS specialist Valcann, a member of the AWS Partner Network (APN), has been crowned…
Read More » -
Press Release
WSPN Partners with Fractal to Expand Stablecoin Access on Bitcoin
SINGAPORE, Dec. 8, 2024 /PRNewswire/ — WSPN (Worldwide Stablecoin Payment Network), a global digital payments company, today announced a strategic…
Read More » -
Press Release
2024 ASH Oral Presentation—-Abbisko presents promising preliminary phase 2 study results of pimicotinib in the treatment of Chronic Graft-versus-Host Disease (cGvHD) at the 66th ASH Annual Meeting
SHANGHAI, Dec. 8, 2024 /PRNewswire/ — December 8, 2024, Abbisko Therapeutics (HKEX: 02256) announced the presentation of preliminary Phase 2…
Read More » -
Press Release
Global Total Semiconductor Equipment Sales Forecast to Reach a Record of $139 Billion in 2026, SEMI Reports
Front-end and Back-end Segments Projected to Support Consecutive Growth from 2024 through 2026 TOKYO, Dec. 9, 2024 /PRNewswire/ — Global sales…
Read More » -
Press Release
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based regimens demonstrate improved rates of minimal residual disease (MRD) negativity and progression-free survival in patients with newly diagnosed multiple myeloma
New analysis from Phase 3 CEPHEUS study demonstrates 85 percent of patients who achieved MRD negativity (10-6) with DARZALEX FASPRO® were…
Read More » -
Press Release
AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients
-New insights show Black, Hispanic, and Asian patients have more negative emotional experiences and outlooks with their chronic lymphocytic leukemia (CLL)…
Read More »
